<DOC>
	<DOCNO>NCT02930044</DOCNO>
	<brief_summary>The purpose study determine whether adult DKA patient present emergency department treat early subcutaneous long act insulin versus standard care receive short total duration intravenous ( IV ) insulin infusion .</brief_summary>
	<brief_title>Early Subcutaneous Insulin Glargine Plus Standard Care Treatment Diabetic Ketoacidosis</brief_title>
	<detailed_description>Specific Aims : To evaluate impact early administration subcutaneous glargine versus standard care time insulin infusion DKA patient secondary outcome list application . Methods : DKA patient enrol study receive long act glargine dose ( 0.3 units/kg maximum dose 30 unit ) within two hour initiation IV insulin infusion . Besides time glargine dose , change standard patient care occur patient enrol study , labs collect insulin infusion titrate use hospital protocol algorithm . Patients enrol prospective arm compare retrospective control group , receive standard insulin therapy ( subcutaneous insulin glargine administer least 2 3 hour prior termination insulin infusion ) . There 18 patient group select reverse chronological order pre-specified date range 8/1/2014 7/31/2016 .</detailed_description>
	<mesh_term>Ketosis</mesh_term>
	<mesh_term>Acidosis</mesh_term>
	<mesh_term>Diabetic Ketoacidosis</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Bicarbonate &lt; 18 mg/dL Anion gap &gt; 16 Blood glucose &gt; 250 mg/dL Ketonemia ketonuria Pregnant woman Refused consent Patient leave ED medical advice</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Emergency department</keyword>
	<keyword>Insulin</keyword>
	<keyword>Adult</keyword>
</DOC>